X

Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
NOT-MH-15-018: Notice to Expire RFA-MH-16-405 "Exploratory Clinical Trials of Novel Interventions for Mental Disorders (R21/R33)"
Notice to Expire RFA-MH-16-405 "Exploratory Clinical Trials of Novel Interventions for Mental Disorders (R21/R33)"

Notice Number: NOT-MH-15-018

Key Dates
Release Date:   April 23, 2015

Related Announcements
RFA-MH-16-406
RFA-MH-16-405

Issued by
National Institute of Mental Health (NIMH)

Purpose

Because the first phase of the project is not feasible within the constraints of the R21 mechanism, NIMH is expiring RFA-MH-16-405, "Exploratory Clinical Trials of Novel Interventions for Mental Disorders (R21/R33)" effective immediately. No applications will be accepted under this FOA.

NIMH intends to publish a new FOA to solicit applications in this area of science in the coming weeks. 

See http://www.nimh.nih.gov/funding/opportunities-announcements/clinical-trials-foas/index.shtml for information on all current NIMH Clinical Trial announcements, FAQs and related publications on CT policies.

Inquiries

Please direct all inquiries to:

For inquiries to the Division of Translational Research (DTR), about all pediatric intervention modalities:

Ann Wagner, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-3633
Email: awagner@mail.nih.gov

For inquiries to the Division of Translational Research (DTR), about all adult intervention modalities:

Mi Hillefors, M.D., Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-1692
Email: hillefom@mail.nih.gov